Filter
844
Filtered Results: 844
Text search:
World
Alliance
for
Patient
Safety
Featured
Recommendations
87
New Publications
223
Language
Document type
No document type
400
Studies & Reports
171
Guidelines
113
Manuals
62
Strategic & Response Plan
52
Training Material
20
Situation Updates
8
Infographics
6
Fact sheets
6
Resource Platforms
3
Brochures
2
Online Courses
1
Countries / Regions
Global
51
India
24
Nigeria
23
Liberia
22
Kenya
22
Sierra Leone
21
South Africa
18
Ethiopia
15
Uganda
15
Syria
14
Zambia
12
Western and Central Europe
12
Namibia
11
Guinea
10
Lesotho
9
Nepal
8
Tanzania
8
Malawi
8
Myanmar / Burma
8
Latin America and the Carribbean
8
Africa
8
Burkina Faso
7
Senegal
7
Ghana
7
Philippines
7
Russia
7
South–East Asia Region
6
Eastern Europe
6
Mali
5
Côte d’Ivoire / Ivory Coast
5
Rwanda
5
Bangladesh
5
Ukraine
5
USA
4
Zimbabwe
4
Haiti
4
South Sudan
4
Botswana
4
East and Southern Africa
4
West and Central Africa
4
Congo, Democratic Republic of
3
Afghanistan
3
Cambodia
3
Eswatini/ Swaziland
3
Yemen
3
Middle East and North Africa
3
Asia
3
Pakistan
2
Germany
2
Indonesia
2
Peru
2
Brazil
2
Angola
2
Albania
2
Georgia
2
Guinea-Bissau
1
Somalia
1
Iraq
1
Thailand
1
Ireland
1
Mozambique
1
Papua New Guinea
1
Ecuador
1
El Salvador
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Laos
1
Canada
1
Timor Leste/ East Timor
1
Vietnam
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
242
Clinical Guidelines
98
Public Health
71
Key Resources
44
Women & Child Health
43
Capacity Building
17
Pharmacy & Technologies
8
Toolboxes
COVID-19
85
Mental Health
77
HIV
57
AMR
53
TB
48
Caregiver
36
Ebola
34
Planetary Health
27
Global Health Education
25
Rapid Response
22
Conflict
21
NCDs
20
Pharmacy
18
NTDs
18
Disability
17
Refugee
16
Health Financing Toolbox
6
Polio
4
Social Ethics
4
Natural Hazards
3
Cholera
2
Zika
2
Specific Hazards
2
The core of the strategy is the goal for all patients to have better overall care, so that the numbers of deaths and cases of disability are reduced by 50% before 2030. ... this to be achieved, four strategic aims will be pursued.
Empower and engage communities,
Ensure safe, effective treatment,
Strengthen health systems, and
Increase partnerships, coordination and resources Strong collaboration
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, th...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
English version - This handbook sets out a the new paradigm for pharmacy practice. Its aim is to guide pharmacy educators in pharmacy practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. The handbook, w...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids ... the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients with non-severe COVID-19 as the treatment brought no benefits, and could even prove harmful. Treatment should be under supervision of a clinician.
Corticosteroids are listed in the WHO model list of essential medicines, readily available globally at a low cost. WHO encourages countries to maintain sufficient stocks of corticosteroids to treat COVID-19 and the other disease for which they are effective, while not maintaining excessive stocks which could deny other countries access.
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on th...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute res...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB ...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Developmen...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vac...
These guidelines provide a recommendation on iodine thyroid blocking (ITB), via oral administration of stable iodine, as an urgent protective action in responding to a nuclear accident. This recommendation aims to support emergency planners, policy makers, public health specialists, clinicians and o...
Primary health care, as outlined in the 1978 Declaration of Alma-Ata and again 40 years later in the 2018 WHO/UNICEF document A vision for primary health care in the 21st century: towards universal health coverage and the Sustainable Development Goa...
Poor quality health services are holding back progress on improving health in countries at all income levels.
Today, inaccurate diagnosis, medication errors, inappropriate or unnecessary treatment, inadequate or unsafe clinical facilities or practices, or providers who lack adequate training an...
Today, inaccurate diagnosis, medication errors, inappropriate or unnecessary treatment, inadequate or unsafe clinical facilities or practices, or providers who lack adequate training an...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
This article summarises the process involved in developing the updated guideline and includes an infographic to highlight key IPC recommendations from the guideline, following the patient care pathway from the community to a healthcare facility to d...
Inequality of access to palliative care and symptom relief is one of the greatest disparities in global health care (1). Currently, there is avoidable suffering on a massive scale due to lack of access to palliative care and symptom relief in low- and middle-income countries (LMICs) (1). Yet basic p...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential com...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
